title: Cysteine-conjugated metabolite of ginger component [6]-shogaol serves as a carrier of [6]-shogaol in cancer cells and in mice.
abstract: Shogaols, a series of major constituents in dried ginger (Zingiber officinale), show high anticancer potencies. Previously, we reported that a major metabolite resulting from the mercapturic acid pathway, 5-cysteinyl-[6]-shogaol (M2), showed comparable growth inhibitory effects toward cancer cells to [6]-shogaol (6S). Here, we probe the mechanism by which M2 exerts its bioactivity. We utilized a series of chemical stability tests in conjunction with bioassays to show that thiol-conjugates display chemopreventative potency by acting as carriers of active ginger component 6S. M2 chemical degradation to 6S was observed in an environment most resembling physiological conditions, with a pH of 7.4 at 37 °C. The metabolic profiles of M2 in cancer cells HCT-116 and H-1299 resembled those of 6S, indicating that its biotransformation route was initiated by deconjugation. Further, the presence of excess glutathione significantly delayed 6S and M2 metabolism and counteracted cell death induced by 6S and M2, suggesting that increasing available free thiols exogenously both promoted the formation of 5-glutathionyl-[6]-shogaol (M13) and inhibited the production of free 6S from M2 deconjugation, resulting in delayed 6S cell entry and bioactivity. Given the chemopreventative properties of M2 and our observations in vitro, we investigated its metabolism in mice. M2 and 6S showed similar metabolic profiles in mouse urine and fecal samples. Six new thiol-conjugated metabolites (M16-M21), together with previously reported ones, were identified by LC/MS. In particular, the increase of 5-N-acetylcystenyl-[6]-shogaol (M5) and its 3'-demethylated product (M16) abundance in mouse feces after treatment with M2 indicates that in addition to acting as a carrier of 6S, M2 is also directly acetylated to M5, which is further demethylated to M16 in vivo. In conclusion, the cysteine-conjugated metabolite of [6]-shogaol M2 exerts its bioactivity by acting as a carrier of 6S in both cancer cells and in mice.
authors: Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, 500 Laureate Way, Kannapolis, North Carolina 28081, USA.
authors: Huadong
authors: H
authors: Chen
authors: Dominique N
authors: DN
authors: Soroka
authors: Yingdong
authors: Y
authors: Zhu
authors: Yuhui
authors: Y
authors: Hu
authors: Xiaoxin
authors: X
authors: Chen
authors: Shengmin
authors: S
authors: Sang
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D002396:Catechols / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003545:Cysteine / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D005260:Female; D020939:Zingiber officinale / Q000737:chemistry*; D045325:HCT116 Cells; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D015394:Molecular Structure; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents; D002396:Catechols; C040115:shogaol; D003545:Cysteine
references: Crit Rev Food Sci Nutr. 2012;52(8):651-88
references: 22591340
references: Mol Nutr Food Res. 2010 Sep;54(9):1296-306
references: 20336681
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Food Chem Toxicol. 2008 Feb;46(2):409-20
references: 17950516
references: Drug Metab Dispos. 2012 Apr;40(4):742-53
references: 22246389
references: Anal Biochem. 2010 Oct 15;405(2):269-71
references: 20541518
references: Nutr Cancer. 2001;41(1-2):17-28
references: 12094621
references: Int J Oncol. 2002 Mar;20(3):631-6
references: 11836580
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Oct 15;907:126-39
references: 23031413
references: Adv Ther. 1998 Jan-Feb;15(1):25-44
references: 10178636
references: Drug Metab Rev. 1985-1986;16(3):255-84
references: 3914937
references: PLoS One. 2012;7(6):e39664
references: 22768104
references: Cancer Res. 2005 Sep 15;65(18):8548-57
references: 16166336
references: Arch Pharm Res. 2008 Apr;31(4):415-8
references: 18449496
references: J Environ Pathol Toxicol Oncol. 1999;18(2):131-9
references: 15281225
references: Cancer Metastasis Rev. 2002;21(3-4):231-55
references: 12549763
references: Forum Nutr. 2009;61:182-192
references: 19367122
references: J Agric Food Chem. 2009 Nov 25;57(22):10645-50
references: 19877681
references: Mutat Res. 1998 Jun 18;402(1-2):259-67
references: 9675305
references: Arthritis Rheum. 2001 Nov;44(11):2531-8
references: 11710709
references: Molecules. 2012 Jul 04;17(7):8037-55
references: 22763741
references: Carcinogenesis. 2012 Jan;33(1):2-9
references: 22080571
references: Biochem Pharmacol. 2006 May 14;71(10):1397-421
references: 16563357
references: Food Chem Toxicol. 2007 May;45(5):683-90
references: 17175086
references: Mol Nutr Food Res. 2013 Mar;57(3):447-58
references: 23322393
references: PLoS One. 2013;8(1):e54677
references: 23382939
references: Chem Res Toxicol. 2001 Sep;14(9):1170-6
references: 11559030
references: Drug Metab Dispos. 2004 Mar;32(3):333-9
references: 14977868